Microtubules and resistance to tubulin-binding agents
- PMID: 20147901
- DOI: 10.1038/nrc2803
Microtubules and resistance to tubulin-binding agents
Erratum in
- Nat Rev Cancer. 2010 Apr;10(4):309
Abstract
Microtubules are dynamic structures composed of alpha-beta-tubulin heterodimers that are essential in cell division and are important targets for cancer drugs. Mutations in beta-tubulin that affect microtubule polymer mass and/or drug binding are associated with resistance to tubulin-binding agents such as paclitaxel. The aberrant expression of specific beta-tubulin isotypes, in particular betaIII-tubulin, or of microtubule-regulating proteins is important clinically in tumour aggressiveness and resistance to chemotherapy. In addition, changes in actin regulation can also mediate resistance to tubulin-binding agents. Understanding the molecular mechanisms that mediate resistance to tubulin-binding agents will be vital to improve the efficacy of these agents.
Similar articles
-
Molecular dynamics simulation and free energy landscape methods in probing L215H, L217R and L225M βI-tubulin mutations causing paclitaxel resistance in cancer cells.Biochem Biophys Res Commun. 2016 Aug 5;476(4):273-279. doi: 10.1016/j.bbrc.2016.05.112. Epub 2016 May 24. Biochem Biophys Res Commun. 2016. PMID: 27233604
-
Novel mutations involving βI-, βIIA-, or βIVB-tubulin isotypes with functional resemblance to βIII-tubulin in breast cancer.Protoplasma. 2017 May;254(3):1163-1173. doi: 10.1007/s00709-016-1060-1. Epub 2016 Dec 9. Protoplasma. 2017. PMID: 27943021
-
Microtubule dynamics, mitotic arrest, and apoptosis: drug-induced differential effects of betaIII-tubulin.Mol Cancer Ther. 2010 May;9(5):1339-48. doi: 10.1158/1535-7163.MCT-09-0679. Epub 2010 May 4. Mol Cancer Ther. 2010. PMID: 20442307
-
Microtubule Targeting Agents as Cancer Chemotherapeutics: An Overview of Molecular Hybrids as Stabilizing and Destabilizing Agents.Curr Top Med Chem. 2017;17(22):2523-2537. doi: 10.2174/1568026617666170104145640. Curr Top Med Chem. 2017. PMID: 28056738 Review.
-
Microtubules: a dynamic target in cancer therapy.IUBMB Life. 2008 Mar;60(3):165-70. doi: 10.1002/iub.25. IUBMB Life. 2008. PMID: 18380008 Review.
Cited by
-
The Role of Microtubules in Pancreatic Cancer: Therapeutic Progress.Front Oncol. 2021 May 21;11:640863. doi: 10.3389/fonc.2021.640863. eCollection 2021. Front Oncol. 2021. PMID: 34094924 Free PMC article. Review.
-
Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel.Oncotarget. 2015 Aug 28;6(25):21740-54. doi: 10.18632/oncotarget.3226. Oncotarget. 2015. PMID: 25844599 Free PMC article. Clinical Trial.
-
Advancing antibody-drug conjugates in gynecological malignancies: myth or reality?Explor Target Antitumor Ther. 2022;3(2):149-171. doi: 10.37349/etat.2022.00077. Epub 2022 Apr 19. Explor Target Antitumor Ther. 2022. PMID: 36046840 Free PMC article. Review.
-
p53-independent structure-activity relationships of 3-ring mesogenic compounds' activity as cytotoxic effects against human non-small cell lung cancer lines.BMC Cancer. 2016 Jul 25;16:521. doi: 10.1186/s12885-016-2585-6. BMC Cancer. 2016. PMID: 27456853 Free PMC article.
-
Methoxy and bromo scans on N-(5-methoxyphenyl) methoxybenzenesulphonamides reveal potent cytotoxic compounds, especially against the human breast adenocarcinoma MCF7 cell line.J Enzyme Inhib Med Chem. 2021 Dec;36(1):1029-1047. doi: 10.1080/14756366.2021.1925265. J Enzyme Inhib Med Chem. 2021. PMID: 34107837 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources